Therefore, the aims of this study were to identify subgroups with similar Hb level trajectories with different breast cancer stages, to determine the independent association cancer stages level trajectories within a specific treatment time interval and long-term survival, and to assess survival with different cancer stages based on Hb trajectories. This evidence concerns the gene GSTM1 and breast cancer.